MicroTransponder Inc.

Interventional pain is on the rise as a specialty and it's presenting investors with an attractive large market offering unmet needs, and, relative to other emerging medical device opportunities, a lo

New company creation slipped significantly in 2009 as venture capitalists conserved capital and supported existing portfolio companies. In biopharmaceuticals, corporate venture got in at the ground fl

by Bob Kronemyer InspireMD: A New Generation of Protected Coronary Stents With safety now a top priority in the coronary stenting arena, stent developers are emphasizing the potential safety benefits

Injectable neural transponder for controlling pain 12147 Lueders Lane Dallas, TX 75230 Phone: (214) 770-0935 Web Site: www.microtransponder.com Contact: Will Rosellini, President & CEO Industry Segmen